文献速递免疫规划传染病防控与疫情报告

COVID-19疫苗接种对感染后状况发生风险的影响:VENUS研究

Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS study.
PubMed 文献 · Vaccine · 2024-11-05

这项回顾性队列研究利用日本四个市町村的医疗索赔、COVID-19病例信息和疫苗接种记录数据库,纳入2020年8月至2022年12月确诊的COVID-19病例,按最近一次疫苗接种与感染间隔分组,监测感染后3、5、8个月36种感染后状况的发生率,并用Cox比例风险模型计算8个月内发生风险。结果显示,84,464名参与者中9,642人(11.4%)在8个月内发生感染后状况;感染前14-149天内接种者中,36种目标状况中的28种8个月发生风险显著较低。结论认为感染前5个月内接种COVID-19疫苗可降低感染后状况的发生率和风险。

要点

  • 84,464名COVID-19病例中,9,642人(11.4%)在8个月内发生感染后状况。
  • 感染前14-149天接种者中,36种目标状况中的28种8个月发生风险显著较低。
  • 作者认为感染前5个月内接种COVID-19疫苗可降低感染后状况的发生率和风险。

核心结论

  • COVID-19疫苗在感染前5个月内接种可降低感染后状况的发生率和风险。
  • 尽管最近接种组的平均年龄最高且合并症患病率最高,其发生感染后状况的风险仍较低。

研究设计与样本

  • 回顾性队列研究,使用日本四个市町村居民的医疗索赔、COVID-19病例信息和疫苗接种记录数据库。
  • 队列纳入2020年8月至2022年12月确诊的COVID-19病例,共84,464人。
  • 按最近一次COVID-19疫苗接种与感染发生的间隔分为≥365天、150-364天和14-149天三组。
  • 监测感染后3、5、8个月36种感染后状况的发生率,并用Cox比例风险模型计算8个月内发生各状况的风险。

主要发现

  • 84,464名参与者中,9,642人(11.4%)在8个月内发生感染后状况。
  • 感染前14-149天内接种者中,36种目标状况中的28种(包括多种呼吸系统状况、心血管状况、炎症和免疫疾病、身体状况、精神状况和内分泌疾病)8个月发生风险显著较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Post-COVID-19 conditions have emerged as a global health challenge. This study examined the long-term effects of COVID-19 vaccination on the incidence and risk of post-COVID-19 conditions in Japan. METHODS: This retrospective cohort study was conducted using a database comprising medical claims, COVID-19 case information, and vaccination records of persons residing in four Japanese municipalities. The cohort included COVID-19 cases diagnosed between August 2020 and December 2022. Participants were classified according to the duration between their most recent COVID-19 vaccination and COVID-19 occurrence (≥365 days, 150-364 days, and 14-149 days). The incidences of 36 post-COVID-19 conditions were monitored for 3, 5, and 8 months after infection. Cox proportional hazards models were used to calculate the risk of developing each post-COVID-19 condition within 8 months after infection according to vaccination status. RESULTS: From among 84,464 participants, 9642 (11.4 %) developed post-COVID-19 conditions over 8 months. The 8-month risks of developing 28 (including various respiratory conditions, cardiovascular conditions, inflammatory and immune diseases, physical conditions, psychiatric conditions, and endocrine disorders) of the 36 target conditions were significantly lower when individuals had been recently vaccinated (14-149 days) before infection. CONCLUSIONS: COVID-19 vaccination can reduce the incidence and risk of post-COVID-19 conditions if administered within 5 months before infection. Despite having the highest mean age and prevalence of comorbidities, individuals who were most recently vaccinated had a lower risk of developing post-COVID-19 conditions. These results provide important evidence for future COVID-19 vaccination strategies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kim SA, Maeda M, Murata F, et al. Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS study. Vaccine. 2024. PMID: 39504683. doi:10.1016/j.vaccine.2024.126497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。